Sriravali Pulipaka

Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe mice

Santosh Karnewar, Sriravali Pulipaka, Sujana Katta et al. · Atherosclerosis · 2022 · 42 citations

Inflammation, Aging, Mitochondrial Function +11

Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation

Sriravali Pulipaka, Gajalakshmi Singuru, Sashikanta Sahoo et al. · GeroScience · 2023 · 20 citations · Full text

Metabolic Syndrome, Oxysterol, Cardiovascular Disease +13

<scp>DOT1L</scp> regulates <scp>MTDH</scp> ‐mediated angiogenesis in triple‐negative breast cancer: intermediacy of <scp>NF‐κB‐HIF1α</scp> axis

Praveen Neeli, Sashikanta Sahoo, Santosh Karnewar et al. · FEBS Journal · 2022 · 19 citations

Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis

Sriravali Pulipaka, Hridya Chempon, Gajalakshmi Singuru et al. · Mechanisms of Ageing and Development · 2024 · 14 citations

SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis

Sashikanta Sahoo, Sunita Kumari, Sriravali Pulipaka et al. · Molecular Carcinogenesis · 2024 · 10 citations